v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Consolidated net loss $ (216,340) $ (271,920)
Adjustments to reconcile net loss including noncontrolling interests to net cash and cash equivalents provided by operations:    
Depreciation and amortization expense 53,734 53,741
Stock-based compensation expense 258,936 240,502
Operating lease non-cash expense 30,300 27,722
(Accretion)/amortization on marketable securities, net (19,368) (19,998)
Amortization of debt issuance costs 351 338
Impairment expense, (gain)/loss on investment and other asset sales, and other, net (215) 63
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 211,324 174,068
Prepaid expenses and other current assets (12,449) (15,310)
Deferred cost of revenue (30,219) (33,368)
Other assets (5,146) 51
Accounts payable 18,967 (3,576)
Accrued expenses and other current liabilities (5,200) (9,221)
Developer exchange liability 6,561 (22,190)
Deferred revenue 175,496 129,184
Operating lease liabilities (25,496) (19,103)
Other long-term liabilities 2,678 7,963
Net cash and cash equivalents provided by operating activities 443,914 238,946
Cash flows from investing activities:    
Acquisition of property and equipment (17,365) (46,680)
Purchases of intangible assets 0 (1,200)
Purchases of investments (1,169,947) (1,032,756)
Maturities of investments 1,000,250 873,820
Sales of investments 151,771 128,232
Net cash and cash equivalents used in investing activities (35,291) (78,584)
Cash flows from financing activities:    
Proceeds from issuance of common stock 36,531 32,670
Financing payments related to acquisitions 0 (4,450)
Net cash and cash equivalents provided by financing activities 36,531 28,220
Effect of exchange rate changes on cash and cash equivalents 1,843 (634)
Net increase/(decrease) in cash and cash equivalents 446,997 187,948
Cash and cash equivalents    
Beginning of period 711,683 678,466
End of period 1,158,680 866,414
Supplemental disclosure of noncash investing and financing activities:    
Property and equipment additions in accounts payable, accrued expenses and other current liabilities, and other long-term liabilities $ 15,093 $ 30,084